In the last decade, there has been rapid progress in the treatment of aortic valve disease with catheter-based therapies. For adults with aortic stenosis, transcatheter aortic valve replacement (TAVR) has become commonplace, with Brigham and Women’s Hospital offering the highest-volume TAVR program in New England.
Ventricular tachycardia (VT) in patients with structural heart disease can be life-threatening and often requires a multi-pronged treatment strategy. While implanted defibrillators can detect arrhythmias, shocks can be painful and sometimes harmful.
Medications can help manage or eliminate VT, but they can have limited efficacy and toxicities. And while radiofrequency catheter ablation can destroy abnormal heart tissues, success rates range from 49 to 75 percent. Read More
When a 54-year-old woman arrived at Brigham and Women’s Hospital, cardiovascular experts at the Heart & Vascular Center (HVC) discovered that her left main and right coronary arteries were 99 percent blocked.
Advances in cancer therapies have allowed clinicians to better manage cancer and extend the lives of patients, but many therapies can produce serious cardiovascular side effects, from arrhythmias and hypertension, to cardiomyopathy and even heart failure.
This November, leading experts in cardiology from Brigham and Women’s Hospital presented new findings and cutting-edge research at the American Heart Association’s (AHA) Scientific Sessions 2019 in Philadelphia.
The NuPulseCV Intravascular Ventricular Assist system (iVAS) is a novel, minimally invasive mechanical circulatory support device that provides long-term support for patients with advanced heart failure who are not benefiting from medications or cardiac resynchronization therapy. Read More
In September 2019, results from the DAPA-HF trial revealed that SGLT2 inhibitors may be helpful for patients with heart failure. These therapies may also be used to prevent heart failure in patients with diabetes*. However, a way of accurately identifying which diabetes patients are most at risk for heart failure has been elusive. Read More
The Division of Cardiac Surgery at Brigham and Women’s Hospital has a rich tradition of innovation, having performed the world’s first successful valve surgery in 1923 and the first heart transplant in New England in 1984. Read More
At the 2019 European Society of Cardiology (ESC) congress, investigators from Brigham Health presented results from highly anticipated cardiovascular trials with the potential to transform clinical practice.